Risperidon-Mepha may be available in the countries listed below.
Ingredient matches for Risperidon-Mepha
Risperidone is reported as an ingredient of Risperidon-Mepha in the following countries:
- Switzerland
International Drug Name Search
Risperidon-Mepha may be available in the countries listed below.
Risperidone is reported as an ingredient of Risperidon-Mepha in the following countries:
International Drug Name Search
Omeprazol Spirig may be available in the countries listed below.
Omeprazole is reported as an ingredient of Omeprazol Spirig in the following countries:
International Drug Name Search
According to one study, patients treated with 3 or more tubes of Regranex had an increased risk of death from cancer. Tell your doctor if you have a history of any type of cancer. Be sure the benefits of using Regranex are greater than the risks. Discuss any questions or concerns with your doctor.
Healing skin ulcers of the lower legs or feet caused by diabetes. It is used in combination with proper wound care.
Regranex is a wound-healing agent. It works by helping the body to form cells involved in wound healing and tissue growth.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Regranex. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Regranex. Because little, if any, of Regranex is absorbed into the blood, the risk of it interacting with another medicine is low.
Ask your health care provider if Regranex may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Regranex as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Regranex.
All medicines may cause side effects, but many people have no, or minor side effects. When used in small doses, no COMMON side effects have been reported with Regranex. Seek medical attention right away if any of these SEVERE side effects occur:
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); irritation.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Regranex side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Regranex may be harmful if swallowed.
Store Regranex in the refrigerator, between 36 and 46 degrees F (2 and 8 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Do not freeze. Do not use the gel after the expiration date at the bottom of the tube. Keep Regranex out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Regranex. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Thioacétazone may be available in the countries listed below.
Thioacétazone (DCF) is also known as Thioacetazone (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
In some countries, this medicine may only be approved for veterinary use.
BAN
0008029-68-3
Anti-inflammatory agent
Dermatological agent: Topical antiseptic
Ichthammol
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
Otreon may be available in the countries listed below.
Cefpodoxime proxetil (a derivative of Cefpodoxime) is reported as an ingredient of Otreon in the following countries:
International Drug Name Search
Espasmotab may be available in the countries listed below.
Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Espasmotab in the following countries:
International Drug Name Search